Anti-Programmed Cell Death Protein 1 Ligand 1 (PDL1) Polyclonal Antibody

CD274; PDCD1LG1; B7-H; B7H1; PD-L1; PDCD1L1; PDCD1-LG1; Programed Death Ligand 1

USAGE

For flow cytometry, the suggested use of this reagent is 1-5 μl per 10^6 cells in 100 μl volume.
Optimal working dilutions could be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Chinese Journal of Cancer Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications NCBI: PMC3937742
Leukemia.? High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial. Pubmed:24732592
Diabetes?Metab Res Rev. PD‐L1 gene polymorphisms and low serum level of PD‐L1 protein are associated to type 1 diabetes in Chile Pubmed:24816853
Lancet Haematol Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study PubMed: 26686046
Eur J Cancer.  High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis. Pubmed:27039170
Journal of Cancer Research and Clinical Oncology Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer article:10.1007
Journal of Hematology & Oncology PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma pubmed:27737703
Lung Cancer. High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer. pubmed:28212990
Oncotarget Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predictssurvival in advanced biliary tract cancer patients treated with palliative chemotherapy. pubmed:27780932
Oncotarget High post-treatment serum levels of soluble programmed cell death ligand 1 predict earlyrelapse and poor prognosis in extranodal NK/T cell lymphoma patients. pubmed:27105512
Oncotarget.  Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma pubmed:27566569
Cancer Immunol Immunother. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy. pubmed:28349165
Leukemia Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients leu2016385a
Medicine Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy. pubmed:28207525
Allergology International  Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients pubmed:27617656
Medicine Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy PMC5319514
American Journal of Respiratory and Critical Care Medicine Soluble Programed Death Receptor 1 Ligand (sPD-L1) in Pleural Fluid of Patients with Malignant Pleural Mesothelioma (MPM) Pdf:10.1164
Clinical Lung Cancer Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer Pubmed:29859759
Journal of Rheumatology Increased levels of soluble programmed death ligand 1 associate with malignancy in patients with dermatomyositis Pubmed:29419471
Translational Oncology High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma Pubmed:29698935
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA788Hu01 Recombinant Programmed Cell Death Protein 1 Ligand 1 (PDL1) Positive Control; Immunogen; SDS-PAGE; WB.
EPA788Hu61 Eukaryotic Programmed Cell Death Protein 1 Ligand 1 (PDL1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA788Hu01 Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDL1) WB; IHC; ICC; IP.
FAA788Hu01 Anti-Programmed Cell Death Protein 1 Ligand 1 (PDL1) Polyclonal Antibody Flow cytometry.
FAA788Hu41 PE-Linked Anti-Programmed Cell Death Protein 1 Ligand 1 (PDL1) Polyclonal Antibody Flow cytometry.
FAA788Hu51 APC-Linked Anti-Programmed Cell Death Protein 1 Ligand 1 (PDL1) Polyclonal Antibody Flow cytometry.
FAA788Hu81 FITC-Linked Anti-Programmed Cell Death Protein 1 Ligand 1 (PDL1) Polyclonal Antibody Flow cytometry.
MAA788Hu22 Monoclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDL1) WB; IHC; ICC; IP.
MAA788Hu21 Monoclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDL1) WB; IHC; ICC; IP.
LAA788Hu72 Biotin-Linked Monoclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDL1) WB; IHC; ICC.
WEA788Hu Wide-range ELISA Kit for Programmed Cell Death Protein 1 Ligand 1 (PDL1) Enzyme-linked immunosorbent assay for Antigen Detection.
SEA788Hu ELISA Kit for Programmed Cell Death Protein 1 Ligand 1 (PDL1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA788Hu CLIA Kit for Programmed Cell Death Protein 1 Ligand 1 (PDL1) Chemiluminescent immunoassay for Antigen Detection.
PSA788Hu01 Antibody Pair for Programmed Cell Death Protein 1 Ligand 1 (PDL1) ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSA788Hu01 ELISA Kit DIY Materials for Programmed Cell Death Protein 1 Ligand 1 (PDL1) Main materials for "Do It (ELISA Kit) Yourself".